Category: Approval/Launch Region: Asia · India Company: Eli Lilly And Co India Pvt Ltd

SEC approves MSD pembrolizumab injunction for additional indications of cervical and esophageal cancers

SEC approves MSD pembrolizumab injunction for additional indications of cervical and esophageal cancers
An expert committee which advises the drug regulator of the country has recommended approval for US-based pharma major Merck

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!